# Cezar Iliescu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/cezar-iliescu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,031 |
| Field | Chemotherapy-induced cardiotoxicity and mitigation |
| h-index | 34 |
| i10-index | 96 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5036321409 |
| ORCID iD | 0000-0002-8817-4579 |
| Works | 509 |

## Researcher papers

- [Cardiotoxicity of the cancer therapeutic agent imatinib mesylate](https://scholariq.org/papers/cardiotoxicity-of-the-cancer-therapeutic-agent-imatinib-mesylate/)
- [Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment](https://scholariq.org/papers/immune-checkpoint-inhibitor-myocarditis-pathophysiological-characteristics/)
- [Vascular Toxicities of Cancer Therapies](https://scholariq.org/papers/vascular-toxicities-of-cancer-therapies/)
- [Cardiovascular Health of Patients With Cancer and Cancer Survivors](https://scholariq.org/papers/cardiovascular-health-of-patients-with-cancer-and-cancer-survivors/)
- [<scp>SCAI</scp> Expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista)](https://scholariq.org/papers/scp-scai-scp-expert-consensus-statement-evaluation-management-and-special/)
- [SCAI expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Intervencionista)](https://scholariq.org/papers/scai-expert-consensus-statement-evaluation-management-and-special-considerations/)
- [Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States](https://scholariq.org/papers/percutaneous-coronary-intervention-in-cancer-patients-a-report-of-the-prevalence/)
- [Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy](https://scholariq.org/papers/immune-checkpoint-inhibitor-myocarditis-elucidating-the-spectrum-of-disease/)
- [Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion](https://scholariq.org/papers/outcomes-of-cancer-patients-undergoing-percutaneous-pericardiocentesis-for/)
- [Cancer as a Risk Factor for Cardiovascular Disease](https://scholariq.org/papers/cancer-as-a-risk-factor-for-cardiovascular-disease/)
- [The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatment (Review)](https://scholariq.org/papers/the-1-2-3-4-of-carcinoid-heart-disease-comprehensive-cardiovascular-imaging-is/)

## Researcher topics

- [Chemotherapy-induced cardiotoxicity and mitigation](https://scholariq.org/topics/chemotherapy-induced-cardiotoxicity-and-mitigation/)
- [Viral Infections and Immunology Research](https://scholariq.org/topics/viral-infections-and-immunology-research/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Inflammatory Myopathies and Dermatomyositis](https://scholariq.org/topics/inflammatory-myopathies-and-dermatomyositis/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.